Myriad Genetics MYGN Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's tax on share settlement?
- Myriad Genetics (MYGN) reported tax on share settlement of $2.9M in Q1 2026.
- How has Myriad Genetics's tax on share settlement changed year-over-year?
- Myriad Genetics's tax on share settlement decreased by 50.0% year-over-year, from $5.8M to $2.9M.
- What is the long-term trend for Myriad Genetics's tax on share settlement?
- Over 4 years (2021 to 2025), Myriad Genetics's tax on share settlement has grown at a -10.7% compound annual growth rate (CAGR), from $11.5M to $7.3M.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.